NURO
Price:
$3.95
Market Cap:
$8.07M
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physician...[Read more]
Industry
Medical - Devices
IPO Date
2004-07-22
Stock Exchange
NASDAQ
Ticker
NURO
According to NeuroMetrix, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.88. This represents a change of -11.88% compared to the average of -1.00 of the last 4 quarters.
The mean historical PE Ratio of NeuroMetrix, Inc. over the last ten years is 180.93. The current -0.88 PE Ratio has changed -148.64% with respect to the historical average. Over the past ten years (40 quarters), NURO's PE Ratio was at its highest in in the June 2018 quarter at 33.46. The PE Ratio was at its lowest in in the March 2021 quarter at -433.06.
Average
180.93
Median
-4.82
Minimum
-47.82
Maximum
1.95K
Discovering the peaks and valleys of NeuroMetrix, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 326.97%
Maximum Annual PE Ratio = 1.95K
Minimum Annual Increase = -106359.95%
Minimum Annual PE Ratio = -47.82
Year | PE Ratio | Change |
---|---|---|
2023 | -0.57 | -76.38% |
2022 | -2.43 | -94.79% |
2021 | -46.72 | -2.30% |
2020 | -47.82 | 326.97% |
2019 | -11.20 | -100.58% |
2018 | 1.95K | -106359.95% |
2017 | -1.83 | -31.09% |
2016 | -2.66 | -61.91% |
2015 | -6.98 | -57.39% |
2014 | -16.38 | -5.44% |
The current PE Ratio of NeuroMetrix, Inc. (NURO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-16.58
5-year avg
-21.75
10-year avg
180.93
NeuroMetrix, Inc.’s PE Ratio is greater than Heart Test Laboratories, Inc. (-445.21), less than ReShape Lifesciences Inc. (-0.31), greater than Inspira Technologies Oxy B.H.N. Ltd. (-2.20), less than OpGen, Inc. (-0.46), less than Bone Biologics Corporation (-0.42), less than Nuwellis, Inc. (-0.10), less than Tivic Health Systems, Inc. (-0.22), less than Talis Biomedical Corporation (-0.06), less than NanoVibronix, Inc. (-0.49), greater than Bluejay Diagnostics, Inc. (-4.04), greater than Vivos Therapeutics, Inc. (-2.69), less than ThermoGenesis Holdings, Inc. (-0.00), less than Sintx Technologies, Inc. (-0.29), greater than Ra Medical Systems, Inc. (-1.15),
Company | PE Ratio | Market cap |
---|---|---|
-445.21 | $3.63M | |
-0.31 | $3.04M | |
-2.20 | $21.29M | |
-0.46 | $7.45M | |
-0.42 | $2.43M | |
-0.10 | $4.64M | |
-0.22 | $1.85M | |
-0.06 | $3.14M | |
-0.49 | $2.03M | |
-4.04 | $2.01M | |
-2.69 | $24.76M | |
-0.00 | $9.51K | |
-0.29 | $5.05M | |
-1.15 | $3.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroMetrix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeuroMetrix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NeuroMetrix, Inc.'s PE Ratio?
How is the PE Ratio calculated for NeuroMetrix, Inc. (NURO)?
What is the highest PE Ratio for NeuroMetrix, Inc. (NURO)?
What is the 3-year average PE Ratio for NeuroMetrix, Inc. (NURO)?
What is the 5-year average PE Ratio for NeuroMetrix, Inc. (NURO)?
How does the current PE Ratio for NeuroMetrix, Inc. (NURO) compare to its historical average?